This upregulation leads to increased expression of ATP-binding cassette subfamily B member 1 (ABCB1) and carnitine palmitoyltransferase 1B (CPT1B), ultimately causing chemotherapy resistance in BC cells [139]. This evidence concerns the gene CPT1B and breast cancer.